BPC-157 vs Pentadeca Arginate
Written by Aaron CuhaReviewed Sep 2026
The short answer
Pentadeca arginate is sold as a better BPC-157. It is the same 15 building block sequence with an arginine salt instead of acetate. It was made as a way around pharmacy rules, and it has no studies of its own.
- BPC-157 people
- 31
- BPC-157 nulls
- 1
- Pentadeca Arginate people
- 0
- Pentadeca Arginate nulls
- 0
Dose
No human dose established
No published study has given BPC-157 as a shot under the skin or as a pill, the ways most buyers take it. Amounts that circulate in forums are not a human dose. Amounts that were given in studies sit in Human evidence on this page.
Commonly reported amounts, in mcg. BPC-157 has no approved label and no completed human dosing trial.
Amounts commonly reported by people buying BPC-157, recorded for this archive's reconstitution calculator, are 250, 500 and 750 mcg. They are self-reports rather than trial doses, and this archive does not recommend any of them. No human dose has been established for BPC-157.
| Reported amount | Where the number comes from |
|---|---|
| 250 mcg | Self-reported in community sources; not a trial amount and not a label dose |
| 500 mcg | Self-reported in community sources; not a trial amount and not a label dose |
| 750 mcg | Self-reported in community sources; not a trial amount and not a label dose |
Dose
No human dose established
No published study on this page has given this compound to people and reported a result.
1 animal study, no human study
First-hand reports are counted on each profile and never added together. This page sets two published records side by side. It does not pick a winner.
Column A
BPC-157Body Protection Compound 157
A lab-made piece of a stomach protein. It has lots of animal studies on tendon, muscle and gut healing. In people there is very little: two enema studies in Croatia, three small clinic reports with nobody to compare against, and one injury study with a dummy group that is still signing people up.
Column B
Pentadeca ArginatePentadeca Arginate (PDA, pentadecapeptide arginate)
Pentadeca arginate is BPC-157 with a different salt. The 15 building blocks are the same. It was made to get around compounding rules. It has no studies of its own, so it borrows BPC-157's evidence, which is almost all animal work.
The mistake this page exists to correct
Sellers present pentadeca arginate as a more stable, next generation peptide with its own advantages. The sequence is the same as BPC-157. What differs is the salt it is paired with. There is no published human or animal study of the arginate form itself. So every claim that it works is borrowed from BPC-157's studies, which are nearly all in animals or cells. A review of BPC-157 found 36 studies, and 35 of them were in animals or cells.
Side by side, on the facts we can check
| What we compare | BPC-157 | Pentadeca Arginate |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| FDA status | Not FDA-approved. In April 2026 the FDA took it off Category 2, its list of pharmacy ingredients with safety worries. In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6, with one member abstaining, in favor of letting pharmacies make it. The FDA's own reviewers had advised against that. The FDA has not acted yet | Not approved; the FDA does not recognize it as a separate substance |
| Half-life | Under 30 minutes in plasma in a two-person pilot; the animal literature describes effects lasting hours to days. | No human pharmacokinetics for either salt form |
| Molecular weight | 1,419.5 Da | 1,419.5 Da for the BPC-157 pentadecapeptide it is based on; supplied as the arginate salt, which is heavier |
| How it works | In animals, BPC-157 helps grow new blood vessels. It works with nitric oxide, a gas the body uses to widen blood vessels. In tendon cells from animals, it raises growth hormone receptors and growth signals. Nobody has found the exact switch it acts on. The FDA's 2026 review gave that as one reason it could not judge whether it should work. In people, very little is known. After an enema, it could not be found in the blood. A two-person test suggests it leaves the blood in under 30 minutes. Animal studies describe effects that last hours to days. | Assumed to work the same way as BPC-157. In animals, BPC-157 seems to help grow new blood vessels and repair tissue. |
| Studies in people | 7 | 0 |
| Evidence | Limited: 3 completed trials, 31 people given it | Animal or lab only: 1 animal study, no human study |
| Legal status, US | Not approved; research use only | Not approved; sold 'for research use only' |
Frequently asked questions
What is the difference between BPC-157 and Pentadeca Arginate?
BPC-157: A lab-made piece of a stomach protein. It has lots of animal studies on tendon, muscle and gut healing. In people there is very little: two enema studies in Croatia, three small clinic reports with nobody to compare against, and one injury study with a dummy group that is still signing people up. Pentadeca Arginate: Pentadeca arginate is BPC-157 with a different salt. The 15 building blocks are the same. It was made to get around compounding rules. It has no studies of its own, so it borrows BPC-157's evidence, which is almost all animal work.
Which has stronger research evidence, BPC-157 or Pentadeca Arginate?
Each compound gets a band worked out from facts we counted, with the math shown. BPC-157 is Limited (3 completed trials, 31 people given it). Pentadeca Arginate is Animal or lab only (1 animal study, no human study). That counts how much has been done in people. It does not rate whether either one works, and neither one is called the winner.
Are BPC-157 and Pentadeca Arginate FDA-approved?
BPC-157: Not FDA-approved. In April 2026 the FDA took it off Category 2, its list of pharmacy ingredients with safety worries. In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6, with one member abstaining, in favor of letting pharmacies make it. The FDA's own reviewers had advised against that. The FDA has not acted yet. Pentadeca Arginate: Not approved; the FDA does not recognize it as a separate substance.
Related posts
Blog articles that cover BPC-157 or Pentadeca Arginate, newest first.
- Regulation / Nov 9, 2026 / 12 minCompounded Peptides: The 10 Conditions in HHS's New 503A Policy, and What Evidence Sits Behind Them
- Healing & Recovery / Sep 27, 2026 / 17 minPeptides for Joint Pain: BPC-157, TB-500, Lorecivivint, Pentosan and Collagen Peptides, Evidence Tiered
- Healing & Recovery / Sep 27, 2026 / 14 minPeptides for Gut Health: BPC-157, KPV and Larazotide Ranked by Human Evidence
- Safety / Sep 27, 2026 / 14 minPeptide Side Effects by Class: What Is Documented, What Is Anecdotal
Reviewed Sep 2026. This page puts two published records side by side. It is for learning, and it is not medical advice. When this site shows a dose, it is the dose a trial or a clinic actually used, or what people say they did, with the source attached. None of it tells you what to take.